Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3,086 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Short-term and long-term outcomes of patients with anti-melanoma differentiation-associated gene 5 antibody-positive dermatomyositis.
Ida T, Furuta S, Fujiwara M, Hiraguri M, Hirose K, Ikeda K, Iwamoto T, Kagami SI, Kobayashi Y, Kurasawa K, Nakagomi D, Oya Y, Sanayama Y, Shimizu T, Tamachi T, Umibe T, Yasui M, Nakajima H. Ida T, et al. Among authors: fujiwara m. Rheumatology (Oxford). 2024 Jan 12:keae011. doi: 10.1093/rheumatology/keae011. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38216799
STAT6 inhibits T-bet-independent Th1 cell differentiation.
Tamachi T, Takatori H, Fujiwara M, Hirose K, Maezawa Y, Kagami S, Suto A, Watanabe N, Iwamoto I, Nakajima H. Tamachi T, et al. Among authors: fujiwara m. Biochem Biophys Res Commun. 2009 May 15;382(4):751-5. doi: 10.1016/j.bbrc.2009.03.101. Epub 2009 Mar 24. Biochem Biophys Res Commun. 2009. PMID: 19324016
Effect of Reduced-Dose vs High-Dose Glucocorticoids Added to Rituximab on Remission Induction in ANCA-Associated Vasculitis: A Randomized Clinical Trial.
Furuta S, Nakagomi D, Kobayashi Y, Hiraguri M, Sugiyama T, Amano K, Umibe T, Kono H, Kurasawa K, Kita Y, Matsumura R, Kaneko Y, Ninagawa K, Hiromura K, Kagami SI, Inaba Y, Hanaoka H, Ikeda K, Nakajima H; LoVAS Collaborators. Furuta S, et al. JAMA. 2021 Jun 1;325(21):2178-2187. doi: 10.1001/jama.2021.6615. JAMA. 2021. PMID: 34061144 Free PMC article. Clinical Trial.
Predictive validity of Lupus Patient-Reported Outcome for damage accrual in patients with systemic lupus erythematosus: the LUNA Registry.
Nose Y, Onishi A, Nishimura K, Yamamoto Y, Sada KE, Ichinose K, Yoshimi R, Ohno S, Yanai R, Kajiyama H, Sato S, Shimojima Y, Fujiwara M, Kida T, Miyawaki Y, Matsuo Y, Tsuji H, Morinobu A, Saegusa J. Nose Y, et al. Among authors: fujiwara m. Rheumatology (Oxford). 2024 Jun 17:keae341. doi: 10.1093/rheumatology/keae341. Online ahead of print. Rheumatology (Oxford). 2024. PMID: 38885408
Evaluating the safety profile of calcineurin inhibitors: cancer risk in patients with systemic lupus erythematosus from the LUNA registry-a historical cohort study.
Ichinose K, Sato S, Igawa T, Okamoto M, Takatani A, Endo Y, Tsuji S, Shimizu T, Sumiyoshi R, Koga T, Kawashiri SY, Iwamoto N, Tamai M, Nakamura H, Origuchi T, Yajima N, Sada KE, Miyawaki Y, Yoshimi R, Shimojima Y, Ohno S, Kajiyama H, Sato S, Fujiwara M, Kawakami A. Ichinose K, et al. Among authors: fujiwara m. Arthritis Res Ther. 2024 Feb 12;26(1):48. doi: 10.1186/s13075-024-03285-x. Arthritis Res Ther. 2024. PMID: 38347556 Free PMC article.
3,086 results